Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2023

Accrued Expenses [Abstract]

Accrued Expenses

Accrued expenses consisted of the following:

	September 30,		December 31,
	2023		2022
Clinical trial costs	$	313,029		333,440
Compensation costs		155,192		85,191
Franchise taxes		—		26,886
Director fees		90,000		—
Other		11,221		11,197
Accrued expenses	$	569,442		456,714